DEFB1 and autoimmune disease: BET proteins contain two bromodomains, and it has been shown that BD1-specific inhibitors phenocopy the effects of pan-BETis whereas BD2 inhibitors are predominantly effective in inflammatory and autoimmune disease models [30].